Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1980 Nov;35(11):807–813. doi: 10.1136/thx.35.11.807

Atopy and bronchial reactivity in older patients with cystic fibrosis.

M J Tobin, O Maguire, D Reen, E Tempany, M X Fitzgerald
PMCID: PMC471388  PMID: 7221975

Abstract

We studied 25 adolescent and adult patients with cystic fibrosis (CF) and 25 control subjects to determine if the prevalence of atopy and bronchial hyperreactivity was increased in this disease. Results showed that atopic symptoms, as defined by history, were more frequently present in the CF patients. Prick testing of the skin produced positive reactions in 88% of the CF group and 36% of the control subjects (p less than 0.001), and the mean number of reactions per subject was significantly higher in the former group (p less than 0.001); reactions to fungal antigens were strikingly positive in the CF group. The CF patients had a significantly higher mean serum IgG4 (p less than 0.001), IgE (p less than 0.01), and higher mean eosinophil count (p less than 0.05). Clear-cut bronchial hyperreactivity was demonstrated in the CF group compared with control subjects. Bronchial provocation with 400 micrograms of histamine led to a greater than 15% fall in the preinhalation FEV1 in 35% of the CF subjects compared with 4% of the control group, with a mean percentage fall of 15% and 3% respectively (p less than 0.001). In the CF group a greater than 15% rise in PEFR occurred in 32% after inhalation of the parasympatholytic, ipratropium bromide (54 micrograms), and in 27% after inhalation of the sympathomimetic, fenoterol (400 micrograms). No correlation was found between bronchial reactivity and atopic status, HLA phenotype pattern, or disease severity. The cause of the increased prevalence of atopy and bronchial reactivity in CF patients remains unknown. However, it is clear that a trial of bronchodilator therapy is warranted in adolescents and young adults with CF.

Full text

PDF
807

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABBOTT V., McCREARY J. F., POCOCK R., BROWN A. Fibrocystic disease of the pancreas. Can Med Assoc J. 1951 May;64(5):419–423. [PMC free article] [PubMed] [Google Scholar]
  2. Bardana E. J., Jr, Sobti K. L., Cianciulli F. D., Noonan M. J. Aspergillus antibody in patients with cystic fibrosis. Am J Dis Child. 1975 Oct;129(10):1164–1167. doi: 10.1001/archpedi.1975.02120470020005. [DOI] [PubMed] [Google Scholar]
  3. Bryant D. H., Burns M. W., Lazarus L. New type of allergic asthma due to IgG "reaginic" antibody. Br Med J. 1973 Dec 8;4(5892):589–592. doi: 10.1136/bmj.4.5892.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bryant D. H., Burns M. W. The relationship between bronchial histamine reactivity and atopic status. Clin Allergy. 1976 Jul;6(4):373–381. doi: 10.1111/j.1365-2222.1976.tb01919.x. [DOI] [PubMed] [Google Scholar]
  5. COOK C. D., HELLIESEN P. J., KULCZYCKI L., BARRIE H., FRIEDLANDER L., AGATHON S., HARRIS G. B., SHWACHMAN H. Studies of respiratory physiology in children. II. Lung volumes and mechanics of respiration in 64 patients with cystic fibrosis of the pancreas. Pediatrics. 1959 Aug;24(2):181–193. [PubMed] [Google Scholar]
  6. Chai H., Farr R. S., Froehlich L. A., Mathison D. A., McLean J. A., Rosenthal R. R., Sheffer A. L., Spector S. L., Townley R. G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975 Oct;56(4):323–327. doi: 10.1016/0091-6749(75)90107-4. [DOI] [PubMed] [Google Scholar]
  7. Chang N., Levison H. The effect of a nebulized bronchodilator administered with or without intermittent positive pressure breathing on ventilatory function in children with cystic fibrosis and asthma. Am Rev Respir Dis. 1972 Dec;106(6):867–872. doi: 10.1164/arrd.1972.106.6.867. [DOI] [PubMed] [Google Scholar]
  8. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  9. Counahan R., Mearns M. B. Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis. Arch Dis Child. 1975 Jun;50(6):477–481. doi: 10.1136/adc.50.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Empey D. W., Laitinen L. A., Jacobs L., Gold W. M., Nadel J. A. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis. 1976 Feb;113(2):131–139. doi: 10.1164/arrd.1976.113.2.131. [DOI] [PubMed] [Google Scholar]
  11. GANDEVIA B., ANDERSON C. The effect of a bronchodilator aerosol on ventilatory capacity in fibrocystic disease of the pancreas. Arch Dis Child. 1959 Dec;34:511–515. doi: 10.1136/adc.34.178.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gold W. M. The role of the parasymphathetic nervous system in airways disease. Postgrad Med J. 1975;51(7 Suppl):53–62. [PubMed] [Google Scholar]
  13. Haluszka J., Sciślicki A. Bronchial lability in children suffering from some diseases of the bronchi. Respiration. 1975;32(3):217–226. doi: 10.1159/000193651. [DOI] [PubMed] [Google Scholar]
  14. KULCZYCKI L. L., MUELLER H., SHWACHMAN H. Respiratory allergy in patients with cystic fibrosis. JAMA. 1961 Feb 4;175:358–364. doi: 10.1001/jama.1961.03040050014004. [DOI] [PubMed] [Google Scholar]
  15. LONGBOTTOM J. L., PEPYS J. PULMONARY ASPERGILLOSIS: DIAGNOSTIC AND IMMUNOLOGICAL SIGNIFICANCE OF ANTIGENS AND C-SUBSTANCE IN ASPERGILLUS FUMIGATUS. J Pathol Bacteriol. 1964 Jul;88:141–151. doi: 10.1002/path.1700880119. [DOI] [PubMed] [Google Scholar]
  16. Landau L. I., Phelan P. D. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis. J Pediatr. 1973 May;82(5):863–868. doi: 10.1016/s0022-3476(73)80085-x. [DOI] [PubMed] [Google Scholar]
  17. McFarlane H., Allan J. D., van der Zeil P. Passive cutaneous anaphylaxis (PCA) and specific IgE in cystic fibrosis and their heterozygotes. Clin Allergy. 1977 May;7(3):279–284. doi: 10.1111/j.1365-2222.1977.tb01453.x. [DOI] [PubMed] [Google Scholar]
  18. Mearns M., Longbottom J., Batten J. Precipitating antibodies to aspergillus fumigatus in cystic fibrosis. Lancet. 1967 Mar 11;1(7489):538–539. doi: 10.1016/s0140-6736(67)92115-0. [DOI] [PubMed] [Google Scholar]
  19. Mellins R. B., Levin O. R., Ingram R. H., Jr, Fishman A. P. Obstructive disease of the airways in cystic fibrosis. Pediatrics. 1968 Mar;41(3):560–573. [PubMed] [Google Scholar]
  20. Mellis C. M., Levison H. Bronchial reactivity in cystic fibrosis. Pediatrics. 1978 Mar;61(3):446–450. [PubMed] [Google Scholar]
  21. Mitchell I., Corey M., Woenne R., Krastins I. R., Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr. 1978 Nov;93(5):744–748. doi: 10.1016/s0022-3476(78)81070-1. [DOI] [PubMed] [Google Scholar]
  22. Parish W. E. Short-term anaphylactic IgG antibodies in human sera. Lancet. 1970 Sep 19;2(7673):591–592. doi: 10.1016/s0140-6736(70)90170-4. [DOI] [PubMed] [Google Scholar]
  23. Poppius H., Salorinne Y. Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis. Br Med J. 1973 Oct 20;4(5885):134–136. doi: 10.1136/bmj.4.5885.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rachelefsky G. S., Osher A., Dooley R. E., Ank B., Stiehm E. R. Coexistent respiratory allergy and cystic fibrosis. Am J Dis Child. 1974 Sep;128(3):355–359. doi: 10.1001/archpedi.1974.02110280085010. [DOI] [PubMed] [Google Scholar]
  25. SCHAYER R. W. Significance of induced synthesis of histamine in physiology and pathology. Chemotherapia (Basel) 1961;3:128–136. doi: 10.1159/000219538. [DOI] [PubMed] [Google Scholar]
  26. Shakib F., Stanworth D. R., Drew R., Catty D. A quantitative study of the distribution of IgG sub-classes in a group of normal human sera. J Immunol Methods. 1975;8(1-2):17–28. doi: 10.1016/0022-1759(75)90077-0. [DOI] [PubMed] [Google Scholar]
  27. Shakib F., Stanworth D. R., Smalley C. A., Brown G. A. Elevated serum IgG4 levels in cystic fibrosis patients. Clin Allergy. 1976 May;6(3):237–240. doi: 10.1111/j.1365-2222.1976.tb01902.x. [DOI] [PubMed] [Google Scholar]
  28. Soothill J. F., Stokes C. R., Turner M. W., Norman A. P., Taylor B. Predisposing factors and the development of reaginic allergy in infancy. Clin Allergy. 1976 Jul;6(4):305–319. doi: 10.1111/j.1365-2222.1976.tb01911.x. [DOI] [PubMed] [Google Scholar]
  29. VAN METRE T. E., Jr, COOKE R. E., GIBSON L. E., WINKENWERDER W. L. Evidence of allergy in patients with cystic fibrosis of the pancreas. J Allergy. 1960 Mar-Apr;31:141–150. doi: 10.1016/0021-8707(60)90037-x. [DOI] [PubMed] [Google Scholar]
  30. WEST J. R., LEVIN S. M., DI SANT'AGNESE P. A. Pulmonary function in cystic fibrosis of the pancreas. Pediatrics. 1954 Feb;13(2):155–164. [PubMed] [Google Scholar]
  31. Wallwork J. C., Brenchley P., McCarthy J., Allan J. D., Moss D., Ward A. M., Holzel A., Williams R. F., McFarlane H. Some aspects of immunity in patients with cystic fibrosis. Clin Exp Immunol. 1974 Nov;18(3):303–320. [PMC free article] [PubMed] [Google Scholar]
  32. Wallwork J. C., McFarlane H. The SIgA system and hypersensitivity in patients with cystic fibrosis. Clin Allergy. 1976 Jul;6(4):349–358. doi: 10.1111/j.1365-2222.1976.tb01915.x. [DOI] [PubMed] [Google Scholar]
  33. Warner J. O., Norman A. P., Soothill J. F. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet. 1976 May 8;1(7967):990–991. doi: 10.1016/s0140-6736(76)91862-6. [DOI] [PubMed] [Google Scholar]
  34. Warner J. O., Taylor B. W., Norman A. P., Soothill J. F. Association of cystic fibrosis with allergy. Arch Dis Child. 1976 Jul;51(7):507–511. doi: 10.1136/adc.51.7.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Warner J. O. The variability of skin test hypersensitivity reactions in cystic fibrosis and asthma. Clin Allergy. 1977 Jul;7(4):385–389. doi: 10.1111/j.1365-2222.1977.tb01467.x. [DOI] [PubMed] [Google Scholar]
  36. Warren C. P., Tai E., Batten J. C., Hutchcroft B. J., Pepys J. Cystic fibrosis--immunological reactions to A. fumigatus and common allergens. Clin Allergy. 1975 Mar;5(1):1–12. doi: 10.1111/j.1365-2222.1975.tb01831.x. [DOI] [PubMed] [Google Scholar]
  37. Zapletal A., Motoyama E. K., Gibson L. E., Bouhuys A. Pulmonary mechanics in asthma and cystic fibrosis. Pediatrics. 1971 Jul;48(1):64–72. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES